ClinicalTrials.Veeva

Menu

Evaluation of Infants With Intrauterine Growth Restriction (ModeInfIUGR)

I

Iuliu Hatieganu University of Medicine and Pharmacy

Status

Unknown

Conditions

Intrauterine Growth Restriction

Study type

Observational

Funder types

Other

Identifiers

NCT02515292
142 /181/ 20.05.2014

Details and patient eligibility

About

Purpose: Clinical assessment (anthropometric) and paraclinical (biochemical and immunological by dosing serum insuline growth factors IGF1 and IGF2 and their receptors) of neonates with intrauterine growth restriction (IUGR) and the integration in a multidimensional statistical model .

Objectives:

  1. IGF1 and IGF2 evaluation of serum and IGF1 receptor, IGF2 receptor and IGF2 receptor gene expression in cord blood from newborns with intrauterine growth restriction (IUGR). (Prospective)
  2. Evaluation and monitoring of anthropometric, clinical (non-cardiac morbidity) and paraclinical. (Retrospective & prospective)
  3. Evaluation and monitoring of morphological and functional by echocardiography. (Prospective)
  4. Integrating multidimensional clinical and paraclinical parameters in a statistical model for evaluating newborn with intrauterine growth restriction.

Enrollment

60 estimated patients

Sex

All

Ages

Under 24 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • newborns with intrauterine growth restriction (IUGR): weight below the 10th percentile for gestational age
  • parental consent for enrollment

Exclusion criteria

  • IUGR neonates in the context chromosomopathies: trisomy 21, trisomy 18.
  • neonates with congenital heart disease
  • twins
  • refusal of parents for participation to the study

Trial design

60 participants in 2 patient groups

IUGR: newborn with intrauterine growth restriction
Description:
Inclusion criteria: * newborn infants with symmetrical (both weight and height lower than 10th percentile) or asymmetrical (birth weight is lower than 10th percentile but height and age-appropriated height) intrauterine growth restriction * agreement of the parents that their child to be included in the study
control: newborn without intrauterine growth restriction
Description:
Inclusion criteria: - matches newborn without intrauterine growth restriction in terms of gender and gestational age as IUGR group

Trial contacts and locations

1

Loading...

Central trial contact

Monica Gabriela Hășmășanu, MD; Sorana D. Bolboacă, PhD Habil

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems